Mitigo Injection
Product Images NDC 66794-160

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Mitigo (NDC 66794-160). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Piramal Critical Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mitigo 1

Line graph titled 'Dose Trend in Continuous Infusions of Intrathecal Morphine' showing mean infusion dose (mg/day) with 95% confidence intervals over infusion duration up to 40 weeks. The graph displays increasing dose trend with shaded confidence interval band and indicates 20 mg/day as lowest dose reported for regional myodonus.*

FDA Label Image

Mitigo 10mg mL Carton

Packaging label for MITIGO Morphine Sulfate Injection USP 200 mg/20 mL (10 mg/mL) single-dose vial by Piramal Critical Care. The preservative-free injection is specified for epidural and intrathecal administration. The label highlights it is not for intravenous, intramuscular, or subcutaneous injection and is intended for neuraxial administration in continuous microinfusion devices.*

FDA Label Image

Mitigo 10mg mL Label

Label for MITIGO Morphine Sulfate Injection USP 200 mg/20 mL (10 mg/mL) single-dose vial. The label specifies it is not for IV, IM, or SC injection, intended for neuraxial administration in continuous microinfusion devices. Manufactured by Piramal Critical Care, with storage instructions and a lot number and expiration date area.*

FDA Label Image

Mitigo 25mg mL Carton

Packaging label for MITIGO Morphine Sulfate Injection USP, 500 mg/20 mL (25 mg/mL) single-dose vial, preservative-free. The label indicates usage is not for intravenous, intramuscular, or subcutaneous injection but for neuraxial administration in continuous microinfusion devices. The product is manufactured by Piramal Critical Care, Inc. The label includes storage instructions and a barcode.*

FDA Label Image

Mitigo 25mg mL Label

Label for MITIGO Morphine Sulfate Injection USP 500 mg/20 mL (25 mg/mL) single-dose vial. The label specifies it is not for IV, IM, or SC injection and is intended for neuraxial administration in continuous microinfusion devices. Manufactured by Piramal Critical Care with storage and usage warnings.*

FDA Label Image

Mitigo Structure

Chemical structure of Morphine Sulfate showing two morphine molecules complexed with sulfuric acid and five water molecules (hydrate form). The diagram identifies key functional groups and ring structures characteristic of morphine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.